SonoClear Study Selected for EANS 2026 Oral Presentation
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
neurostimulation
Advertisement
Nervonik Completes First Human Nerve Sensing Study
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
Amgen’s IMDYLLTRA Wins EU Approval for Small Cell Lung Cancer
THOUSAND OAKS, Calif., June 1, 2026 Amgen has secured a major regulatory milestone with the European Commission approval of...
NeuroPace Wins FDA Approval for AI-Powered Epilepsy Tool
MOUNTAIN VIEW, Calif., May 29, 2026 NeuroPace, Inc., a leading medical technology company focused on transforming the treatment of...
Nyxoah Expands Genio Sleep Apnea Therapy Access
Middle East Partnership Advances Neurostimulation Care – February 18, 2026 | Mont-Saint-Guibert, Belgium Nyxoah has signed a Memorandum of...
Advertisements
Cortigent Showcases Orion Brain Implant Clinical Progress
EMERYVILLE, Calif., January 22, 2026 — Vivani Medical announced that its wholly owned subsidiary Cortigent will present advanced clinical...
Nyxoah Begins U.S. Launch of Genio System for Sleep Apnea
MONT-SAINT-GUIBERT, Belgium, Oct. 6, 2025 — Nyxoah SA announced that the first U.S. commercial patients have been implanted with...
Advertisement
